Tender Details

Country: Japan
Summary: A Palivizumab (Genetical Recombination) (100 Mg/1 Ml/1 Vial) 468 Vials,And 64 other Contracts
JPT Ref No: 62341451
Deadline: 17 Mar 2022
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.:
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
A Palivizumab (Genetical Recombination) (100 mg/1 mL/1 vial) 468 vials,and 64 other contracts
Classification :
0004 Medical & Pharmaceutical Products
Summay of Notice :
⑴ Official in charge of disbursement of the procuring entity : Takeo Matsuno, Acting President, Asahikawa Medical University
⑵ Classification of the products to be procured : 4
⑶ Nature and quantity of the products to be purchased :
A Palivizumab (Genetical Recombination) (100 mg/1 mL/1 vial) 468 vials
B Goserelin Acetate (11.3 mg/1 syringe) 636 syringes
C Fulvestrant (250 mg/5 mL/2 syringes/1 case) 678 cases
D Risankizumab (Genetical Recombination) (75 mg/0.83 mL/1 syringe) 200 syringes
E Ravulizumab (Genetical Recombination) (300 mg/30 mL/1 vial) 140 vials
F Eribulin Mesilate (1 mg/2 mL/1 vial) 648 vials
G Mepolizumab (Genetical Recombination) (100 mg/1 mL/1 cartridge) 241 cartridges
H Botulinum Toxin Type A (100 units/1 vial) 335 vials
I Pomalidomide (4 mg/7 capsules/1 case) 310 cases
J Lenalidomide Hydrate (5.174 mg/40 capsules/1 case) 194 cases
K Canakinumab (Genetical Recombination) (150 mg/1 vial) 112 vials
L Onasemnogene abeparvovec (1 set) 1 set
M Brolucizumab (Genetical Recombination) (19.8 mg/0.165 mL/1 kit) 121 kits
N Somatropin (Genetical Recombination) (10 mg/1 syringe) 336 syringes
O Ipilimumab (Genetical Recombination) (50 mg/10 mL/1 vial) 78 vials
P Cetuximab (G...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

A Palivizumab (Genetical Recombination) (100 Mg/1 Ml/1 Vial) 468 Vials,And 64 other Contracts - Japan Tender

The NATIONAL UNIVERSITY CORPORATION, a Government sector organization in Japan, has announced a new tender for A Palivizumab (Genetical Recombination) (100 Mg/1 Ml/1 Vial) 468 Vials,And 64 other Contracts. This tender is published on JapanTenders under JPT Ref No: 62341451 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-03-17.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.